Literature DB >> 8739820

Measurement of 5-fluorouracil in scalp hair: a possible index of patient compliance with oral adjuvant chemotherapy.

T Uematsu1, M Nakashima, M Fujii, K Hamano, M Yasutomi, S Kodaira, T Kato, K Kotake, H Oka, T Masuike.   

Abstract

OBJECTIVE: Little is known about patient compliance with oral adjuvant chemotherapy. It is estimated to be poor especially in Japan, where it is still unusual for patients to be directly informed of their diagnosis of malignancy. 5-Fluorouracil (5-FU) was measured in hair samples to assess patient exposure to 5-FU, and its potential usefulness is discussed as an index of compliance with postoperative adjuvant chemotherapy.
METHODS: Hair samples obtained from 55 patients, who had received oral 5-FU (total dose 27-41 g) as postoperative adjuvant chemotherapy over a 6-month period, were used for the analysis of 5-FU. The drug was extracted from the hair using ethyl acetate, and its fluorescence derivatization was employed for measurement with HPLC. The detection limit of 5-FU in hair was 0.01 ppm.
RESULTS: In 22 out of 55 samples 5-FU content was under the detection limit, whereas in the remaining 33 samples the drug was detected in a range of 0.006-2.125 ng per hair strand; in addition, drug content showed a lognormal distribution. 5-FU was detected in the hair collected from those patients who were possibly compliant with the postoperative oral adjuvant chemotherapy.
CONCLUSION: As many as 40% of the patients analysed were supposed to be much less compliant. Even in the possibly compliant patients, the degree of compliance with the therapy varied according to a log-normal distribution.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739820     DOI: 10.1007/s002280050077

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  3 in total

Review 1.  Therapeutic drug monitoring of antimetabolic cytotoxic drugs.

Authors:  L Lennard
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

Review 2.  Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature.

Authors:  Krishna Patel; Nathan R Foster; Ann Farrell; Nguyet Anh Le-Lindqwister; Josy Mathew; Brian Costello; John Reynolds; Jeffrey P Meyers; Aminah Jatoi
Journal:  J Cancer Educ       Date:  2013-12       Impact factor: 2.037

3.  Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.

Authors:  Aurélie Bourmaud; Emilie Henin; Fabien Tinquaut; Véronique Regnier; Chloé Hamant; Olivier Colomban; Benoit You; Florence Ranchon; Jérôme Guitton; Pascal Girard; Gilles Freyer; Michel Tod; Catherine Rioufol; Véronique Trillet-Lenoir; Franck Chauvin
Journal:  BMC Res Notes       Date:  2015-07-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.